Sept.23, the Science and Technology Committee of Pudong New Area announced the winner’s list for 2008 Pudong’s R&D Enterprises. Hutchison MediPharma was honored to be selected as one of the Pudong R&D Enterprises.
Shanghai Pudong Science and Technology Administration formulated policies and regulations on accreditation of Pudong Research and Development Enterprises to enhance the establishment of enterprise-centered technology innovation systems and strengthen the development of hi-tech industry in the Pudong New Area. The regulations emphasized operational performance, management mechanism, mid-term and long-term development plans and goals for participating companies. In addition, regulation set a series of evaluation standards regarding the structured ratio of R&D staff, R&D investment and patent exploitation of participating companies. Approved companies will be labeled as Pudong’s Research and Development Enterprises, acquire bronze plates from the Pudong New Area and receive government R&D subsidies and etc.
Hutchison MediPharma started the preparation for application in the beginning of 2008. With one-year preparation and comprehensive deployment, Hutchison MediPharma was successfully selected as Pudong R&D Enterprise. This merit represents a high recognition of Hutchison MediPharma’s strong R&D capability from local government and will serve as a driving power for Hutchison MediPharma in the course of new drug research and development.